Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Diabetes Complications. 2016 Jul 25;30(8):1577–1584. doi: 10.1016/j.jdiacomp.2016.07.014

Table 1.

Baseline Characteristics by Hp genotype

HP 1-1 or HP 2-1
(N=787)
HP 2-2
(N=516)
p-value*
Intensive treatment group 399 (51) 237 (46) 0.092
Age (years) 27 ± 7 27 ± 7 0.667
BMI (kg/m2) 23.4 ± 2.8 23.4 ± 2.8 0.730
Duration of type 1 diabetes in months 66 ± 49 70 ± 51 0.259
Female 379 (48) 230 (45) 0.205
Baseline HbA1c (%) 8.8 ± 1.5 8.9 ± 1.6 0.104
Baseline HbA1c (mmol/mol) 72.7 ± 16.9 74.3 ± 17.6 0.104
Primary cohort 402 (51) 249 (48) 0.319
Clinical neuropathy = yes 48 (6) 32 (6) 0.958
Smoker = yes 145 (18) 101 (20) 0.604
LDL (mg/dL) 108 ± 29 111 ± 30 0.082
HDL (mg/dL) 50 ± 12 50 ± 12 0.652
Triglycerides (mg/dL) 82 ± 49 82 ± 48 0.682
Cholesterol (mg/dL) 175 ± 33 178 ± 35 0.132
Blood pressure (mm Hg)
  Systolic 114 ± 12 115 ± 11 0.171
  Diastolic 73 ± 9 72 ± 9 0.990
Estimated Glomerular Filtration Rate
(mL/min/1.73m2)
125.5 ± 14.0 126.0 ± 13.3 0.441
Albumin excretion rate (mg/24 h) 15.8 ± 17.3 15.9 ± 20.8 0.862

Data are N (%) and mean ± SD.

*

Wilcoxon for continuous variables and chi-square test for categorical variables.